New HIV prevention drug could reach poorer countries by 2025, health official says By Reuters
By Jennifer Rigby LONDON (Reuters) - A new long-acting HIV preventive drug could reach the world's poorest countries in late ...
By Jennifer Rigby LONDON (Reuters) - A new long-acting HIV preventive drug could reach the world's poorest countries in late ...
By Michael Erman, Patrick Wingrove and Maggie Fick NEW YORK (Reuters) - The U.S. pharmaceutical industry is pushing to renew ...
By Jonathan Stempel (Reuters) - Walgreens Boots Alliance has agreed to pay $106.8 million to settle charges that it fraudulently ...
The Chai Discovery team announced the launch of Chai-1an innovative multimodal base model designed to predict molecular structures with unprecedented ...
Miscellaneous photos/iStock Editorial via Getty Images Healthcare providers are outraged at Johnson & Johnson (New York Stock Exchange:JNJ) after the ...
<!-- <meta http-equiv="x-UA-Compatible" content="IE=edge"/> <link rel="alternate" href="https://www.financebrokerage.com/abos-stock-alzheimer-drug/" hreflang="x-default"/> ABOS Stock: Can Acumen’s Alzheimer’s Drug Boost ...
Nineteen members of Congress Mark Zuckerberg explains why Meta has allowed ads for cocaine, ecstasy and other drugs to appear ...
By Jeff Mason, Patrick Wingrove and Trevor Hunnicutt LARGO, Maryland/WASHINGTON (Reuters) - The United States has negotiated a price cut ...
Transcription: CONWAY GITTENS: I'm Conway Gittens reporting from the New York Stock Exchange. Here's what we're watching today on TheStreet.stocks ...
The Terray Therapeutics laboratory is a symphony of miniaturized automation. The robots rotate and transport small tubes of fluids to ...